Viemed director exercises 18,786 RSUs into stock

VIEMED HEALTHCARE, INC.

Rhea-AI Filing Summary

VIEMED HEALTHCARE, INC. (VMD) reported equity compensation and an RSU conversion by director Kaushal Nitin. On August 19, 2026, 18,786 Restricted Stock Units were exercised/converted into 18,786 common shares, bringing his directly held common shares to 161,361. Each RSU represents a contingent right to receive one common share. Separately, on August 17, 2026, he received a grant of 15,217 RSUs tied to an equal number of common shares, scheduled to vest on August 17, 2027.

Insider Trade Summary

18,786 shares exercised/converted

Exercise 3 txns

Insider Kaushal Nitin

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F2	18,786	$0.00	$0.00
Exercise	Common Shares F1	18,786	--	--
Grant/Award	Restricted Stock Units F1, F3	15,217	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 15,217 contracts (Direct); Common Shares — 161,361 shares (Direct)

Footnotes (3)

1. F1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
2. F2. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
3. F3. On August 17, 2026, the reporting person was granted Restricted Stock Units which vest on August 17, 2027.

Key Figures

RSUs converted: 18,786 shares Common shares after transaction: 161,361 shares New RSU grant: 15,217 RSUs +3 more

6 metrics

RSUs converted 18,786 shares Restricted Stock Units exercised/converted into common shares on August 19, 2026

Common shares after transaction 161,361 shares Directly held Viemed common shares following the August 19, 2026 conversion

New RSU grant 15,217 RSUs Restricted Stock Units granted on August 17, 2026, each for one common share

RSU vesting date (new grant) August 17, 2027 Vesting date for the 15,217 RSUs granted August 17, 2026

RSU vesting date (prior grant) August 19, 2026 Vesting date for RSUs granted August 19, 2025 that were exercised August 19, 2026

RSU-to-share ratio 1 RSU : 1 common share Each Restricted Stock Unit represents a contingent right to one common share

Key Terms

Restricted Stock Units, derivative security, grant, award, or other acquisition

3 terms

Restricted Stock Units financial

"Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity transactions did VMD director Kaushal Nitin report on this Form 4?

Director Kaushal Nitin reported exercising 18,786 RSUs into 18,786 Viemed common shares on August 19, 2026, and receiving a new grant of 15,217 RSUs on August 17, 2026 that vest on August 17, 2027.

How many VIEMED HEALTHCARE (VMD) common shares does Kaushal Nitin own after these transactions?

After the August 19, 2026 RSU conversion, Kaushal Nitin directly holds 161,361 Viemed common shares. This figure reflects his position immediately following the reported exercise of 18,786 Restricted Stock Units into common shares.

What are the details of the new RSU grant reported by VMD for Kaushal Nitin?

On August 17, 2026, Kaushal Nitin received 15,217 Restricted Stock Units, each representing a contingent right to one Viemed common share. These RSUs are scheduled to vest on August 17, 2027, subject to the applicable award terms.

What does the RSU conversion reported by VMD on August 19, 2026 involve?

The conversion involved 18,786 Restricted Stock Units being exercised or converted into 18,786 Viemed common shares on August 19, 2026. The derivative RSU position decreased while directly held common shares increased accordingly for the reporting person.

Do the RSUs reported by VMD for Kaushal Nitin correspond one-for-one to common shares?

Yes. Each Restricted Stock Unit (RSU) represents a contingent right to receive one Viemed common share. Thus, grants of 15,217 RSUs and conversions of 18,786 RSUs correspond to equal numbers of underlying common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:31 PM Accepted by SEC EDGAR 08/19/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaushal Nitin

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LOUISIANA 70508

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/19/2026		M		18,786	A	(1)	161,361	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/19/2026		M			18,786	(2)	(2)	Common Shares	18,786	$0	0	D
Restricted Stock Units	(1)	08/17/2026		A		15,217		(3)	08/17/2027	Common Shares	15,217	$0	15,217	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.

3. On August 17, 2026, the reporting person was granted Restricted Stock Units which vest on August 17, 2027.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)